Physician

Richard Ellis Larew, M.D.

According to 2025 Medicare claims, Richard Larew, M.D. (NPI: 1003880592) practices internal medicine in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is LAREW INTERNAL MEDICINE PLC (NPI: 1134780687; TIN: 833607226) and primary practice location at 52245-9556.

Larew's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 207 traditional Medicare patients, billed 10,808 HCPCS/CPT codes, and received $165,750 in Medicare payments. The top billing code was 82150 (Amylase (enzyme) level). Part D data shows 3,545 prescription claims across 396 beneficiaries totaling $498,401 in drug costs, led by Ozempic (Semaglutide). DME data shows 41 claims. Open Payments data shows 3 records totaling $57. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $270,463 to $498,401. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $10,228 and ending at $7,798.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	526	16,054	$215,615
2016	584	12,807	$204,986
2017	613	17,478	$180,921
2018	564	14,722	$165,498
2019	417	7,686	$91,272
2020	208	4,460	$90,386
2021	240	6,560	$123,452
2022	195	12,002	$139,219
2023	195	8,296	$156,415
2024	207	10,808	$165,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	463	8,669	$270,463
2016	547	8,632	$273,727
2017	566	7,971	$277,135
2018	702	7,802	$385,919
2019	829	6,251	$392,770
2020	352	2,217	$226,700
2021	176	2,520	$242,689
2022	143	2,509	$308,003
2023	745	3,578	$590,317
2024	396	3,545	$498,401

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	67	217	$5,151
2016	64	220	$4,318
2017	61	304	$5,083
2018	93	290	$5,468
2019	77	211	$2,572
2020	13	60	$585
2021	N/R	27	$173
2022	N/R	19	$184
2023	N/R	68	$3,396
2024	N/R	41	$1,504

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82150	Amylase (enzyme) level	160	469	$6
82310	Calcium level, total	160	468	$5
82565	Blood creatinine level	160	468	$5
82247	Bilirubin level, total	160	468	$5
82040	Albumin (protein) level	160	466	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	73	2,963	$92,529
Eliquis	Apixaban	65	3,588	$64,986
Arexvy	Rsvpref3 Antigen/As01e/Pf	200	200	$58,783
Mounjaro	Tirzepatide	35	1,036	$38,189
Xifaxan	Rifaximin	11	330	$33,782

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$1,151
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	17	$209
K0001	Standard wheelchair	Y	N/R	11	$144

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$57	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Ellis Larew, M.D.?

Tedicare shows public-source Medicare data for Richard Ellis Larew, M.D. (NPI 1003880592), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Ellis Larew, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Ellis Larew, M.D.?

Richard Ellis Larew, M.D. is linked to LAREW INTERNAL MEDICINE PLC (billing NPI 1134780687) in the available physician profile data.

Does Richard Ellis Larew, M.D. have Open Payments data?

Richard Ellis Larew, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.